BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21788300)

  • 21. Immediate and mid-term results of transfemoral aortic valve implantation using either the Edwards Sapien transcatheter heart valve or the Medtronic CoreValve System in high-risk patients with aortic stenosis.
    Attias D; Himbert D; Ducrocq G; Détaint D; Al-Attar N; Iung B; Francis F; Maury JM; Brochet E; Enguerrand D; Nataf P; Vahanian A
    Arch Cardiovasc Dis; 2010 Apr; 103(4):236-45. PubMed ID: 20656634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors and prognostic value of myocardial injury during transcatheter aortic valve implantation.
    Yong ZY; Wiegerinck EM; Boerlage-van Dijk K; Koch KT; Vis MM; Bouma BJ; Henriques JP; Cocchieri R; Piek JJ; de Mol BA; Baan J
    Circ Cardiovasc Interv; 2012 Jun; 5(3):415-23. PubMed ID: 22668556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transapical aortic valve implantation in patients with severely depressed left ventricular function.
    Unbehaun A; Pasic M; Buz S; Dreysse S; Kukucka M; Hetzer R; Drews T
    J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1356-63. PubMed ID: 21840548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single center experience with transcatheter aortic valve implantation using the Edwards SAPIEN™ Valve.
    Nielsen HH; Thuesen L; Egeblad H; Poulsen SH; Klaaborg KE; Jakobsen CJ; Andersen HR; Hjortdal VE
    Scand Cardiovasc J; 2011 Oct; 45(5):261-6. PubMed ID: 21506661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN™ and Medtronic CoreValve ReValving System® devices: the Milan registry.
    Buchanan GL; Chieffo A; Montorfano M; Maisano F; Latib A; Godino C; Cioni M; Gullace MA; Franco A; Gerli C; Alfieri O; Colombo A
    EuroIntervention; 2011 Sep; 7(5):556-63. PubMed ID: 21930459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sutureless aortic valve replacement: catheter-based transapical versus direct transaortic implantation.
    Doss M; Buhr E; Moritz A; Martens S
    J Heart Valve Dis; 2012 Nov; 21(6):758-63. PubMed ID: 23409358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcatheter aortic valve implantation: anesthetic considerations.
    Billings FT; Kodali SK; Shanewise JS
    Anesth Analg; 2009 May; 108(5):1453-62. PubMed ID: 19372319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of implant failure during transcatheter aortic valve implantation.
    Ussia GP; Barbanti M; Immè S; Scarabelli M; Mulè M; Cammalleri V; Aruta P; Pistritto AM; Capodanno D; Deste W; Di Pasqua MC; Tamburino C
    Catheter Cardiovasc Interv; 2010 Sep; 76(3):440-9. PubMed ID: 20506152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrocardiographic and imaging predictors for permanent pacemaker requirement after transcatheter aortic valve implantation.
    Koos R; Mahnken AH; Aktug O; Dohmen G; Autschbach R; Marx N; Hoffmann R
    J Heart Valve Dis; 2011 Jan; 20(1):83-90. PubMed ID: 21404902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation.
    Dewey TM; Brown DL; Herbert MA; Culica D; Smith CR; Leon MB; Svensson LG; Tuzcu M; Webb JG; Cribier A; Mack MJ
    Ann Thorac Surg; 2010 Mar; 89(3):758-67; discussion 767. PubMed ID: 20172123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation.
    Buellesfeld L; Stortecky S; Heg D; Hausen S; Mueller R; Wenaweser P; Pilgrim T; Gloekler S; Khattab AA; Huber C; Carrel T; Eberle B; Meier B; Boekstegers P; Jüni P; Gerckens U; Grube E; Windecker S
    J Am Coll Cardiol; 2012 Aug; 60(6):493-501. PubMed ID: 22726632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
    ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is transapical aortic valve implantation really less invasive than minimally invasive aortic valve replacement?
    Zierer A; Wimmer-Greinecker G; Martens S; Moritz A; Doss M
    J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1067-72. PubMed ID: 19740493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis.
    Ussia GP; Barbanti M; Cammalleri V; Scarabelli M; Mulè M; Aruta P; Pistritto AM; Immè S; Capodanno D; Sarkar K; Gulino S; Tamburino C
    EuroIntervention; 2011 Sep; 7(5):573-9. PubMed ID: 21930461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter aortic valve implantation: lessons from the learning curve of the first 270 high-risk patients.
    Gurvitch R; Tay EL; Wijesinghe N; Ye J; Nietlispach F; Wood DA; Lichtenstein S; Cheung A; Webb JG
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):977-84. PubMed ID: 21656647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis.
    Ueshima D; Nai Fovino L; Mojoli M; Napodano M; Fraccaro C; Tarantini G
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):E159-E167. PubMed ID: 30019825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prosthesis depth and conduction disturbances after last generation balloon-expandable transcatheter aortic valve implantation.
    Iacovelli F; Pignatelli A; Giugliano G; Stabile E; Cicala M; Salemme L; Cioppa A; Popusoi G; Pucciarelli A; Verdoliva S; Bortone AS; Losi MA; Coscioni E; Esposito G; Contegiacomo G; Tesorio T
    Europace; 2018 Jan; 20(1):116-123. PubMed ID: 28339584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent annual permanent pacemaker implantation rate after surgical aortic valve replacement in patients with severe aortic stenosis.
    Van Mieghem NM; Head SJ; de Jong W; van Domburg RT; Serruys PW; de Jaegere PP; Jordaens L; Takkenberg JJ; Bogers AJ; Kappetein AP
    Ann Thorac Surg; 2012 Oct; 94(4):1143-9. PubMed ID: 22698776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation.
    Nuis RJ; Van Mieghem NM; Tzikas A; Piazza N; Otten AM; Cheng J; van Domburg RT; Betjes M; Serruys PW; de Jaegere PP
    Catheter Cardiovasc Interv; 2011 May; 77(6):881-9. PubMed ID: 21061244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors and outcomes after transcatheter aortic valve implantation using different approaches according to the valve academic research consortium definitions.
    Seiffert M; Schnabel R; Conradi L; Diemert P; Schirmer J; Koschyk D; Linder M; Kersten JF; Grosser A; Wilde S; Blankenberg S; Reichenspurner H; Baldus S; Treede H
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):640-52. PubMed ID: 23172652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.